Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren’s Syndrome (original) (raw)

Abstract

w and swallowing 11. As a result of reduced salivary secretion, these patients have a higher risk of developing caries, candidiasis, and mucositis and they may also suffer from bad breath (halitosis) and difficulties wearing dentures 12. Consequently, dry mouth often results in reduced quality of life 13. Dry eye disease (DED), defined by the 2007 International Dry Eye Workshop (DEWS), is "a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface" 14. Symptoms of DED include ocular burning and foreign body sensation, soreness, stinging, irritation, reduced visual acuity, photophobia, double vision, and ocular pain. Burden of DED can vary from mild discomfort in daily activities to incapacitation in physical functioning 14. Oral and ocular symptoms in pSS can be relieved with saliva and tear substitutes and stimulants, while involvement of the extra-glandular organs such as kidneys, lungs, skin, joints and muscles may require systemic treatment 15. The range of symptoms associated with multiple organ involvement make pSS a complex disease to handle, for patients, dentists, rheumatologists and other health workers 16. Patients with SS have a 6-fold increased risk of developing non-Hodgkin's lymphoma (NHL), and the lifetime risk of developing lymphoma is 5-10% 5. Interestingly, findings from salivary gland biopsies such as the presence of germinal centres may be a predictor for lymphoma development 17. Interdisciplinary, comprehensive evaluation of pSS including rheumatological examinations, and detailed examinations of dry mouth and dry eyes together with histopathological investigations may therefore have an important role in subgrouping the patients, and in turn benefit the choice of treatment strategies. Furthermore, detailed knowledge about the interplay between symptoms and findings of oral and ocular dryness is lacking. The aim of this study was to comprehensively investigate oral and ocular symptoms and findings in pSS patients and to perform comparisons with age-and gender-matched healthy and sicca control groups. A further aim was to explore possible correlations between oral and ocular findings in the pSS group.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (51)

  1. Fox, P. C. Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy. Annals of the New York Academy of Sciences 1098, 15-21 (2007).
  2. Delaleu, N., Jonsson, R. & Koller, M. M. Sjogren's syndrome. European journal of oral sciences 113, 101-113 (2005).
  3. Fox, R.I. Sjögren's syndrome. Lancet 366, 321-331 (2005).
  4. Shiboski, S. et al. American College of Rheumatology Classification Criteria for Sjögren's Syndrome: A Data-Driven, Expert Consensus Approach in the SICCA Cohort. Arthritis Care Res (Hoboken) 64, 475-487 (2012).
  5. Theander, E. & Jacobsson, L. T. Relationship of Sjogren's syndrome to other connective tissue and autoimmune disorders. Rheumatic diseases clinics of North America 34(935-947), viii-ix (2008).
  6. Ramos-Casals, M., Brito-Zeron, P., Siso-Almirall, A. & Bosch, X. Primary Sjogren syndrome. BMJ (Clinical research ed.) 344, e3821, (2012).
  7. Voulgarelis, M. & Tzioufas, A. G. Pathogenetic mechanisms in the initiation and perpetuation of Sjogren's syndrome. Nature reviews. Rheumatology 6, 529-537 (2010).
  8. Fox, P. C. et al. Oral involvement in primary Sjogren syndrome. Journal of the American Dental Association 139(1592-1601), 2008 (1939).
  9. Patel, R. & Shahane, A. The epidemiology of Sjogren's syndrome. Clinical epidemiology 6, 247-255 (2014).
  10. Ettinger, R. L. Review: xerostomia: a symptom which acts like a disease. Age and ageing 25, 409-412 (1996).
  11. Cassolato, S. F. & Turnbull, R. S. Xerostomia: clinical aspects and treatment. Gerodontology 20, 64-77 (2003).
  12. Turner, M., Jahangiri, L. & Ship, J. A. Hyposalivation, xerostomia and the complete denture: a systematic review. Journal of the American Dental Association 139(146-150), 2008 (1939).
  13. Gerdin, E. W. et al. Impact of dry mouth conditions on oral health-related quality of life in older people. Gerodontology 22, 219-226 (2005).
  14. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Report No. 1542-0124 (Print)1542-0124, 75-92 (2007).
  15. Kassan, S. S. & Moutsopoulos, H. M. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 164, 1275-1284 (2004).
  16. Lopez-Jornet, P. & Camacho-Alonso, F. Quality of life in patients with Sjogren's syndrome and sicca complex. Journal of oral rehabilitation 35, 875-881 (2008).
  17. Theander, E. et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome. Annals of the rheumatic diseases 70, 1363-1368 (2011).
  18. Vitali, C. et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American- European Consensus Group. Annals of the rheumatic diseases 61, 554-558 (2002).
  19. Oyri, H., Bjornland, T., Barkvoll, P. & Jensen, J. L. Mandibular third molar surgery in 396 patients at a Norwegian university clinic: Morbidity recorded after 1 week utilizing an e-infrastructure for clinical research. Acta odontologica Scandinavica 74, 148-154 (2015).
  20. Thomson, W. M. et al. Shortening the xerostomia inventory. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 112, 322-327 (2011).
  21. Thomson, W. M., Chalmers, J. M., Spencer, A. J. & Williams, S. M. The Xerostomia Inventory: a multi-item approach to measuring dry mouth. Community dental health 16, 12-17 (2000).
  22. Osailan, S. M., Pramanik, R., Shirlaw, P., Proctor, G. B. & Challacombe, S. J. Clinical assessment of oral dryness: development of a scoring system related to salivary flow and mucosal wetness. Oral surgery, oral medicine, oral pathology and oral radiology 114, 597-603 (2012).
  23. Grigoriou M, E. T., Øveraasen HC, Palm Ø, Garen T, Jensen JL. Quality of life, oral dryness and clinical findings in patients with Sjögren's Syndrome. Nor Tannlegeforen Tid 820-826, (2014).
  24. McMonnies, C. W. & Ho, A. Responses to a dry eye questionnaire from a normal population. Journal of the American Optometric Association 58, 588-591 (1987).
  25. Nichols, K. K., Nichols, J. J. & Mitchell, G. L. The reliability and validity of McMonnies Dry Eye Index. Cornea 23, 365-371 (2004).
  26. Schiffman, R. M., Christianson, M. D., Jacobsen, G., Hirsch, J. D. & Reis, B. L. Reliability and validity of the Ocular Surface Disease Index. Archives of ophthalmology (Chicago, Ill.: 1960) 118, 615-621 (2000).
  27. Rege, A., Kulkarni, V., Puthran, N. & Khandgave, T. A Clinical Study of Subtype-based Prevalence of Dry Eye. Journal of clinical and diagnostic research: JCDR 7, 2207-2210 (2013).
  28. Miller, K. L. et al. Minimal clinically important difference for the ocular surface disease index. Archives of ophthalmology (Chicago, Ill.: 1960) 128, 94-101 (2010).
  29. Versura, P. & Campos, E. C. TearLab(R) Osmolarity System for diagnosing dry eye. Expert review of molecular diagnostics 13, 119-129 (2013).
  30. Foulks, G. N. et al. Clinical guidelines for management of dry eye associated with Sjogren disease. The ocular surface 13, 118-132 (2015).
  31. Lee, J. H. & Kee, C. W. The significance of tear film break-up time in the diagnosis of dry eye syndrome. Korean journal of ophthalmology: KJO 2, 69-71 (1988).
  32. Bron, A. J., Evans, V. E. & Smith, J. A. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22, 640-650 (2003).
  33. Jacobi, C. J., A., Kruse, F. E. & Cursiefen, C. Tear film osmolarity measurements in dry eye disease using electrical impedance technology. Cornea 30, 1289-1292 (2011).
  34. Senchyna, M. & Wax, M. B. Quantitative assessment of tear production: A review of methods and utility in dry eye drug discovery. J Ocul Biol Dis Infor 1, 1-6 (2008).
  35. Bunya, V. Y. et al. Tear Osmolarity in Sjogren's Syndrome. Cornea 32, 922-927 (2013).
  36. Tomlinson, A. K., Ramaesh, S., Diaper, K., McFadyen, C. & Tear, A. film osmolarity: determination of a referent for dry eye diagnosis. Investigative ophthalmology & visual science 47, 4309-4315 (2006).
  37. Versura, P. P. & Campos, V. E. C. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. Current eye research 35, 553-564 (2010).
  38. Wang, Z. et al. Minor salivary glands function is decreased in hyposalivation-related diseases. Archives of oral biology 69, 63-70 (2016).
  39. Shinozaki, S. et al. Close association between oral Candida species and oral mucosal disorders in patients with xerostomia. Oral diseases 18, 667-672 (2012).
  40. Gabbriellini, G. et al. Ocular Surface Disease Index (OSDI): a potential useful instrument for the assessment of vision-targeted health-related quality of life (VT-HRQ) in primary Sjogren's syndrome (pSS) clinical trials? Clinical and experimental rheumatology 30, 812-813 (2012).
  41. Fostad, I. G. et al. Dry Eye Disease Patients with Xerostomia Report Higher Symptom Load and Have Poorer Meibum Expressibility. PloS one 11, e0155214 (2016).
  42. Szalai, E., Berta, A., Szekanecz, Z., Szucs, G. & Modis, L. Jr. Evaluation of tear osmolarity in non-Sjogren and Sjogren syndrome dry eye patients with the TearLab system. Cornea 31, 867-871 (2012).
  43. Lopez-Miguel, A. et al. Clinical and Molecular Inflammatory Response in Sjogren Syndrome-Associated Dry Eye Patients Under Desiccating Stress. American journal of ophthalmology 161(133-141), e131-132 (2015).
  44. Lim, S. A., Nam, S., Kwok, S. K., Park, S. H. & Chung, S. H. Serologic Markers Are Associated With Ocular Staining Score in Primary Sjogren Syndrome. Cornea 34, 1466-1470 (2015).
  45. Rose-Nussbaumer, J. et al. Inter-grader Agreement of the Ocular Staining Score in the Sjögren's International Clinical Collaborative Alliance (SICCA) registry. American journal of ophthalmology 160(1150-1153), e1153 (2015).
  46. Gayton, J. L. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol 3, 405-412 (2009).
  47. Scully, C. Drug effects on salivary glands: dry mouth. Oral diseases 9, 165-176 (2003).
  48. Shiboski, C. H. S. et al. X. American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjogren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol 69, 35-45 (2016).
  49. Liu, B., Dion, M. R., Jurasic, M. M., Gibson, G. & Jones, J. A. Xerostomia and salivary hypofunction in vulnerable elders: prevalence and etiology. Oral surgery, oral medicine, oral pathology and oral radiology 114, 52-60 (2012).
  50. Lin, P. Y. et al. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 110, 1096-1101 (2003).
  51. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). The ocular surface 5, 93-107 (2007).